BNT162b2 mRNA COVID-19ワクチン接種後に発症したEBウイルス関連リンパ増殖性疾患

Overview of attention for article published in [Rinshō ketsueki] The Japanese journal of clinical hematology, April 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#2 of 727)
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter: 95 X users

Citations

dimensions_citation: 1 Dimensions

Summary X Dimensions citations

So far, Altmetric has seen 112 X posts from 95 X users, with an upper bound of 288,812 followers.

RT @mRNAdeaths: Epstein-Barr virus-associated lymphoproliferative disorders after Pfizer 79-yo male went to the hospital with a 2-week hist…

09 Apr 2024

Reply Repost Favourite

[Epstein-Barr virus-associated lymphoproliferative disorders after BNT162b2 mRNA COVID-19 vaccination] "Although the mechanisms and risk factors for EBV-LPD after BNT162b2 mRNA COVID-19 vaccination remain unknown" https://t.co/GvuxZRalDs:

02 Mar 2024

Reply Repost Favourite

@MarcoST9304 @Robertonuzzoam Studio di caso clinico: Disturbi linfoproliferativi associati al virus Epstein-Barr dopo Pfizer in 79enne morto 2 mesi dopo essersi presentato in ospedale con ancitopenia, livelli elevati di transaminasi epatiche, iperferritine

22 Feb 2024

Reply Repost Favourite

RT @ChanceGardiner: Studio di caso clinico: Disturbi linfoproliferativi associati al virus Epstein-Barr dopo Pfizer in 79enne morto 2 mesi…

22 Feb 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 108 additional X posts.